Showing results (21-30 of 82) with videos related to

Sort By:
Pageof 9
Journal of Immunology (Baltimore, Md. : 1950)|February 4, 2015
Heterogeneous CD3 expression levels in differing T cell subsets correlate with the in vivo anti-CD3-mediated T cell modulationAndrea Valle, Giulia Barbagiovanni, Tatiana Jofra, et al.
Oncoimmunology|May 31, 2019
A novel combination of chemotherapy and immunotherapy controls tumor growth in mice with a human immune systemAude Burlion, Rodrigo N Ramos, Pukar Kc, et al.
Oncoimmunology|November 18, 2017
mRNA Expression levels of genes involved in antitumor immunity: Identification of a 3-gene signature associated with prognosis of muscle-invasive bladder cancerConstance Le Goux, Sophie Vacher, Géraldine Pignot, et al.
Cancer Immunology Research|January 18, 2019
IL2/Anti-IL2 Complex Combined with CTLA-4, But Not PD-1, Blockade Rescues Antitumor NK Cell Function by Regulatory T-cell ModulationPamela Caudana, Nicolas Gonzalo Núñez, Philippe De La Rochere, et al.
Brain : a Journal of Neurology|February 26, 2016
Regulatory T cells delay disease progression in Alzheimer-like pathologyCira Dansokho, Dylla Ait Ahmed, Saba Aid, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 20, 2006
Pertussis toxin reduces the number of splenic Foxp3+ regulatory T cellsCécile Cassan, Eliane Piaggio, Jacques P Zappulla, et al.
Transplantation and Cellular Therapy|March 30, 2025
Simple, Rapid, Reproducible and Biomarker-Validated Clinical Grading System for Murine Models of Xenogeneic Graft-Versus-Host DiseaseAllan Thiolat, Cécile Pivert, Romane Bariseel, et al.
Oncoimmunology|April 4, 2022
Innate lymphoid cells: NK and cytotoxic ILC3 subsets infiltrate metastatic breast cancer lymph nodesLouise Rethacker, Maxime Boy, Valeria Bisio, et al.
Clinical Immunology (Orlando, Fla.)|March 1, 2014
Sustained stimulation and expansion of Tregs by IL2 control autoimmunity without impairing immune responses to infection, vaccination and cancerGuillaume Churlaud, Veronica Jimenez, Jesus Ruberte, et al.
Vaccine|May 8, 2016
Heparan sulfates targeting increases MHC class I- and MHC class II-restricted antigen presentation and CD8(+) T-cell responseDelphine Knittel, Adeline Gadzinski, Stéphane Hua, et al.
Pageof 9